MyCartis technologies: accelerate innovation in biomarker analysis
Every individual has the right to good health. But we know that the current healthcare model of ‘one size fits all’ is insufficient and unsustainable. To continue to be effective, healthcare needs a radical change in the way it sees health and disease. That radical change is the personalization of healthcare. Something that requires a fundamentally new way of looking at things, a healthcare revolution.
That revolution can only be realized by providing a new level of proteomics and genomics information. Information that will enable care givers and later people to accurately identify current and predict future health issues, taking an active role in shaping their health. This level of information enables precise clinical decisions and better prediction of healthcare risks on an individual level and therefore shift healthcare from cure to prevention. Resulting in an increased level of quality of life for everyone.
MyCartis operates at the forefront of biomarker analysis by offering the next generation multiplex biomarker analysis platform : the EVALUTION. Continue reading »